Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Zhihui Jiang, Xianxia He & Jian Li. (2018) Synergy effect of meropenem-based combinations against Acinetobacter baumannii: a systematic review and meta-analysis. Infection and Drug Resistance 11, pages 1083-1095.
Read now
Read now
Yun Cai, Nan Bai, Xu Liu, Beibei Liang, Jin Wang & Rui Wang. (2016) Tigecycline: Alone or in combination?. Infectious Diseases 48:7, pages 491-502.
Read now
Read now
Articles from other publishers (20)
Onur Unal, Onur Kaya, Tuba Ozturk, Emel Sesli Cetin, Ibak Gonen, Esra Nurlu Temel & Fusun Zeynep Akcam. (2023)
Evaluation of combination therapies with colistin in an experimental mouse pneumonia model induced by carbapenem‐resistant
Acinetobacter baumannii
strain
. Fundamental & Clinical Pharmacology 37:4, pages 816-823.
Crossref
Crossref
Sazlyna Mohd Sazlly Lim, Aaron Heffernan, Saiyuri Naicker, Steven Wallis, Jason A. Roberts & Fekade Bruck Sime. (2022) Evaluation of Fosfomycin-Sulbactam Combination Therapy against Carbapenem-Resistant Acinetobacter baumannii Isolates in a Hollow-Fibre Infection Model. Antibiotics 11:11, pages 1578.
Crossref
Crossref
Stamatis Karakonstantis, Petros Ioannou & Diamantis D. Kofteridis. (2022) In search for a synergistic combination against pandrug-resistant A. baumannii; methodological considerations. Infection 50:3, pages 569-581.
Crossref
Crossref
Stamatis Karakonstantis, Petros Ioannou, George Samonis & Diamantis P. Kofteridis. (2021) Systematic Review of Antimicrobial Combination Options for Pandrug-Resistant Acinetobacter baumannii. Antibiotics 10:11, pages 1344.
Crossref
Crossref
Sazlyna Mohd Sazlly Lim, Aaron J. Heffernan, Hosam M. Zowawi, Jason A. Roberts & Fekade B. Sime. (2021) Semi-mechanistic PK/PD modelling of meropenem and sulbactam combination against carbapenem-resistant strains of Acinetobacter baumannii. European Journal of Clinical Microbiology & Infectious Diseases 40:9, pages 1943-1952.
Crossref
Crossref
S. V. Yakovlev, M. P. Suvorova & A. O. Bykov. (2021) Cefepime/Sulbactam — A New Innovative Antibiotic for In-Hospital Treatment of Severe Infections and the Implementation of Carbapenem-Replacement Strategy to Contain Antibiotic Resistance. Antibiotics and Chemotherapy 66:3-4, pages 82-98.
Crossref
Crossref
Sazlyna Mohd Sazlly Lim, Aaron J. Heffernan, Jason A. Roberts & Fekade B. Sime. (2021) Semimechanistic Pharmacokinetic/Pharmacodynamic Modeling of Fosfomycin and Sulbactam Combination against Carbapenem-Resistant Acinetobacter baumannii. Antimicrobial Agents and Chemotherapy 65:5.
Crossref
Crossref
S. V. Yakovlev, M. P. Suvorova, A. O. Bykov, S. V. Zhuravel, K. A. Popugaev, L. Yu. Kulagina, I. N. Ochakovskaya, M. G. Fedorova, O. V. Pribytkova, A. A. Zateyshchikova, O. G. Malkova, T. N. Malorodova, E. S. Nekaeva, N. G. Ogonkin, Yu. A. Strezh, I. N. Sychev, O. I. Tazieva & S. G. Fominykh. (2021) An Open-Label, Multicenter, Observational Study of The Effectiveness of The Cefepime/Sulbactam Antibiotic (Maxictam<sup>®</sup>-AF) In Patients With Intra Abdominal Infection, Nosocomial Pneumonia or Ventilator-Associated Pneumonia (Study MAXI-2019). Antibiotics and Chemotherapy 65:11-12, pages 49-58.
Crossref
Crossref
Liang Meng, Lingti Kong, Chenchen Wu, Benquan Qi & Xiaofei Wu. (2019) Pharmacokinetics of cefoperazone/sulbactam in plasma and cerebrospinal fluid in patients with intraventricular hemorrhage after external ventricular drains. European Journal of Clinical Pharmacology 76:1, pages 127-129.
Crossref
Crossref
Sazlyna Mohd Sazlly Lim, Fekade Bruck Sime & Jason A. Roberts. (2019) Multidrug-resistant Acinetobacter baumannii infections: Current evidence on treatment options and the role of pharmacokinetics/pharmacodynamics in dose optimisation. International Journal of Antimicrobial Agents 53:6, pages 726-745.
Crossref
Crossref
Hua Zhou, Yake Yao, Bingquan Zhu, Danhong Ren, Qing Yang, Yiqi Fu, Yunsong Yu & Jianying Zhou. (2019) Risk factors for acquisition and mortality of multidrug-resistant Acinetobacter baumannii bacteremia. Medicine 98:13, pages e14937.
Crossref
Crossref
Fang Chen, Ling Wang, Min Wang, Yixin Xie, Xiaomeng Xia, Xianping Li, Yanhua Liu, Wei Cao, Tingting Zhang, Pengling Li & Min Yang. (2017) Genetic characterization and in�vitro activity of antimicrobial combinations of multidrug-resistant Acinetobacter�baumannii from a general hospital in China. Oncology Letters.
Crossref
Crossref
Jian LiXianghai YangLidan ChenXinran DuanZhihui Jiang. (2017)
In Vitro
Activity of Various Antibiotics in Combination with Tigecycline Against
Acinetobacter baumannii
: A Systematic Review and Meta-Analysis
. Microbial Drug Resistance 23:8, pages 982-993.
Crossref
Crossref
N Shafiq, G Kumar, V Gautam, P Ray & S Malhotra. (2016) Fixed-dose combinations of antimicrobials: A need for special attention. Indian Journal of Medical Microbiology 34:2, pages 208-209.
Crossref
Crossref
Giancarlo Ceccarelli, Alessandra Oliva, Gabriella d’Ettorre, Alessandra D’Abramo, Elena Caresta, Caterina Silvia Barbara, Maria Teresa Mascellino, Paola Papoff, Corrado Moretti, Vincenzo Vullo, Paolo Visca & Mario Venditti. (2015) The role of vancomycin in addition with colistin and meropenem against colistin-sensitive multidrug resistant Acinetobacter baumannii causing severe infections in a Paediatric Intensive Care Unit. BMC Infectious Diseases 15:1.
Crossref
Crossref
Yan Bai, Bin Liu, Tianlin Wang, Yun Cai, Beibei Liang, Rui Wang, Youning Liu & Jin Wang. (2015)
In Vitro
Activities of Combinations of Rifampin with Other Antimicrobials against Multidrug-Resistant Acinetobacter baumannii
. Antimicrobial Agents and Chemotherapy 59:3, pages 1466-1471.
Crossref
Crossref
Wentao Ni, Xiaodi Shao, Xiuzhen Di, Junchang Cui, Rui Wang & Youning Liu. (2015) In vitro synergy of polymyxins with other antibiotics for Acinetobacter baumannii: A systematic review and meta-analysis. International Journal of Antimicrobial Agents 45:1, pages 8-18.
Crossref
Crossref
A. Batirel, I. I. Balkan, O. Karabay, C. Agalar, S. Akalin, O. Alici, E. Alp, F. A. Altay, N. Altin, F. Arslan, T. Aslan, N. Bekiroglu, S. Cesur, A. D. Celik, M. Dogan, B. Durdu, F. Duygu, A. Engin, D. O. Engin, I. Gonen, E. Guclu, T. Guven, C. A. Hatipoglu, S. Hosoglu, M. K. Karahocagil, A. U. Kilic, B. Ormen, D. Ozdemir, S. Ozer, N. Oztoprak, N. Sezak, V. Turhan, N. Turker & H. Yilmaz. (2014) Comparison of colistin–carbapenem, colistin–sulbactam, and colistin plus other antibacterial agents for the treatment of extremely drug-resistant Acinetobacter baumannii bloodstream infections. European Journal of Clinical Microbiology & Infectious Diseases 33:8, pages 1311-1322.
Crossref
Crossref
Wentao Ni, Junchang Cui, Beibei Liang, Yun Cai, Nan Bai, Xuejiu Cai & Rui Wang. (2013) In vitro effects of tigecycline in combination with colistin (polymyxin E) and sulbactam against multidrug-resistant Acinetobacter baumannii. The Journal of Antibiotics 66:12, pages 705-708.
Crossref
Crossref
Gokcen Dinc, Hayati Demiraslan, Ferhan Elmali, Salman Shaheer Ahmed, Gokhan Metan, Emine Alp & Mehmet Doganay. (2013) Efficacy of Sulbactam and Its Combination with Imipenem, Colistin and Tigecycline in an Experimental Model of Carbapenem-Resistant <b><i>Acinetobacter baumannii</i></b> Sepsis. Chemotherapy 59:5, pages 325-329.
Crossref
Crossref